These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1043 related items for PubMed ID: 23351584
1. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio. Kappelle PJ, Gansevoort RT, Hillege HJ, Wolffenbuttel BH, Dullaart RP, PREVEND Study Group. J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584 [Abstract] [Full Text] [Related]
2. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study. Borggreve SE, Hillege HL, Wolffenbuttel BH, de Jong PE, Zuurman MW, van der Steege G, van Tol A, Dullaart RP, PREVEND Study Group. J Clin Endocrinol Metab; 2006 Sep; 91(9):3382-8. PubMed ID: 16684835 [Abstract] [Full Text] [Related]
3. Complementary prediction of cardiovascular events by estimated apo- and lipoprotein concentrations in the working age population. The Health 2000 Study. Oksala N, Seppälä I, Hernesniemi J, Lyytikäinen LP, Kähönen M, Mäkelä KM, Reunanen A, Jula A, Ala-Korpela M, Lehtimäki T. Ann Med; 2013 Mar; 45(2):141-8. PubMed ID: 22524251 [Abstract] [Full Text] [Related]
7. The association of HDL cholesterol concentration with the -629C>A CETP promoter polymorphism is not fully explained by its relationship with plasma cholesteryl ester transfer. Dullaart RP, Borggreve SE, Hillege HL, Dallinga-Thie GM. Scand J Clin Lab Invest; 2008 Mar; 68(2):99-105. PubMed ID: 17852818 [Abstract] [Full Text] [Related]
8. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD. Clin Chem Lab Med; 2004 Mar; 42(12):1355-63. PubMed ID: 15576296 [Abstract] [Full Text] [Related]
11. Effect of antiatherogenic L-aspartate and L-glutamate on serum lipoproteins cholesterol and apolipoproteins A-1 and B in rabbits fed with high cholesterol diet. Yanni AE, Perrea DN, Yatzidis HA. Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):161-5. PubMed ID: 15955463 [Abstract] [Full Text] [Related]
12. The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy. de Grooth GJ, Zerba KE, Huang SP, Tsuchihashi Z, Kirchgessner T, Belder R, Vishnupad P, Hu B, Klerkx AH, Zwinderman AH, Jukema JW, Sacks FM, Kastelein JJ, Kuivenhoven JA. J Am Coll Cardiol; 2004 Mar 03; 43(5):854-7. PubMed ID: 14998629 [Abstract] [Full Text] [Related]
13. High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides. Borggreve SE, Hillege HL, Dallinga-Thie GM, de Jong PE, Wolffenbuttel BH, Grobbee DE, van Tol A, Dullaart RP, PREVEND Study Group. Eur Heart J; 2007 Apr 03; 28(8):1012-8. PubMed ID: 17409111 [Abstract] [Full Text] [Related]
14. [Association between insulin resistance and cholesteryl ester transfer protein gene polymorphism in type 2 diabetes mellitus]. Jiang T, Song XX, Zhang M, Qi WH, Zhang XW. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun 03; 22(3):298-301. PubMed ID: 15952120 [Abstract] [Full Text] [Related]